David Shaw’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-24,900
Closed -$1.65M – 4796
2025
Q3
$1.65M Buy
+24,900
New +$1.48M ﹤0.01% 3112

Other funds holding IRON

David Shaw's IRON Position: Q3 2026 in Review

David Shaw increased its Disc Medicine (IRON) stake by 606% in Q3 2026, buying an estimated $2.76M and bringing the position to 42,549 shares worth $2.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2957.

David Shaw first reported a position in IRON in Q4 2021 and has held it in 5 quarters since. The position peaked at $10.9M in Q1 2025. 236 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

  • David Shaw held 42,549 shares of Disc Medicine worth $2.79M as of Q3 2026.
  • David Shaw bought 36,522 Disc Medicine shares in Q3 2026, an estimated $2.76M.
  • Disc Medicine made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #2957 holding.
  • David Shaw first reported a position in Disc Medicine in Q4 2021 and has held it in 5 quarters since.
  • David Shaw's Disc Medicine position peaked at $10.9M in Q1 2025.
  • 236 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.